December 20, 2021

Helsinn and Xediton sign exclusive license and distribution agreement for TRUSELTIQ™ (infigratinib) in Canada

Helsinn and Xediton sign exclusive license and distribution agreement for TRUSELTIQ™ (infigratinib) in Canada Lugano, Switzerland, and Mississauga, Ontario, 20 December 2021 – Helsinn Group (Helsinn), a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer supportive care and oncology therapeutics, strategically investing in a fully integrated targeted therapy structure to develop, manufacture and

Read More

ISW Holdings Inc. (ISWH) Reports Record Revenue, Forecasts $7M Per Month

NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) — via InvestorWire — ISW Holdings Inc. (OTC: ISWH) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication and forward-looking statements, please visit: https://nnw.fm/YrdIL Developments

Read More

Recent Posts